Long-Term Therapy with Corticosteroids in Nasal Polyposis

A Bone Metabolism Assessment

M. Gelardi, F. Barbara, I. Covelli, M. A. Damiani, F. Plantone, A. Notarnicola, B. Moretti, N. Quaranta, G. Ciprandi

Research output: Contribution to journalArticle

Abstract

Chronic rhinosinusitis associated with nasal polyposis (RSCwNP) affects 4% of the general population. As chronic condition, it requires chronic pharmacological treatment, whereas the surgical approach becomes necessary in obstructive and/or complicated cases. Intranasal and systemic corticosteroids (CS) represent the “Gold Standard” treatment for RSCwNP. The present study aimed to evaluate the side effects of prednisone in a group of patients with RSCwNP treated with long-term CS. In particular, attention was focused on bone disorders (osteopenia and osteoporosis) and prospective fracture risk increase. Forty patients (26 females, mean age 55.70 ± 14.03 years) affected by RSCwNP have been enrolled. Control group included 40 healthy subjects (17 females, mean age 56.37 ± 13.03 years). Nasal endoscopy, skin prick tests, nasal cytology, and bone densitometry were evaluated in all subjects. The likelihood of impaired bone metabolism (osteopenia or osteoporosis) was superimposable in both groups. Within RSCwNP group, no parameter was statistically significant in predicting a metabolism alteration.

Original languageEnglish
JournalIndian Journal of Otolaryngology and Head and Neck Surgery
DOIs
Publication statusAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Nose
Adrenal Cortex Hormones
Bone and Bones
Metabolic Bone Diseases
Osteoporosis
Therapeutics
Nasal Bone
Densitometry
Prednisone
Skin Tests
Endoscopy
Cell Biology
Healthy Volunteers
Pharmacology
Control Groups
Population

Keywords

  • Chronic rhinosinusitis
  • Corticosteroids
  • Densitometry
  • Nose-sinus polyposis
  • Osteoporosis

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Gelardi, M., Barbara, F., Covelli, I., Damiani, M. A., Plantone, F., Notarnicola, A., ... Ciprandi, G. (Accepted/In press). Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment. Indian Journal of Otolaryngology and Head and Neck Surgery. https://doi.org/10.1007/s12070-018-1466-5

Long-Term Therapy with Corticosteroids in Nasal Polyposis : A Bone Metabolism Assessment. / Gelardi, M.; Barbara, F.; Covelli, I.; Damiani, M. A.; Plantone, F.; Notarnicola, A.; Moretti, B.; Quaranta, N.; Ciprandi, G.

In: Indian Journal of Otolaryngology and Head and Neck Surgery, 01.01.2018.

Research output: Contribution to journalArticle

Gelardi, M, Barbara, F, Covelli, I, Damiani, MA, Plantone, F, Notarnicola, A, Moretti, B, Quaranta, N & Ciprandi, G 2018, 'Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment', Indian Journal of Otolaryngology and Head and Neck Surgery. https://doi.org/10.1007/s12070-018-1466-5
Gelardi, M. ; Barbara, F. ; Covelli, I. ; Damiani, M. A. ; Plantone, F. ; Notarnicola, A. ; Moretti, B. ; Quaranta, N. ; Ciprandi, G. / Long-Term Therapy with Corticosteroids in Nasal Polyposis : A Bone Metabolism Assessment. In: Indian Journal of Otolaryngology and Head and Neck Surgery. 2018.
@article{68265c6586e640aa9c7e61508d99c4fa,
title = "Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment",
abstract = "Chronic rhinosinusitis associated with nasal polyposis (RSCwNP) affects 4{\%} of the general population. As chronic condition, it requires chronic pharmacological treatment, whereas the surgical approach becomes necessary in obstructive and/or complicated cases. Intranasal and systemic corticosteroids (CS) represent the “Gold Standard” treatment for RSCwNP. The present study aimed to evaluate the side effects of prednisone in a group of patients with RSCwNP treated with long-term CS. In particular, attention was focused on bone disorders (osteopenia and osteoporosis) and prospective fracture risk increase. Forty patients (26 females, mean age 55.70 ± 14.03 years) affected by RSCwNP have been enrolled. Control group included 40 healthy subjects (17 females, mean age 56.37 ± 13.03 years). Nasal endoscopy, skin prick tests, nasal cytology, and bone densitometry were evaluated in all subjects. The likelihood of impaired bone metabolism (osteopenia or osteoporosis) was superimposable in both groups. Within RSCwNP group, no parameter was statistically significant in predicting a metabolism alteration.",
keywords = "Chronic rhinosinusitis, Corticosteroids, Densitometry, Nose-sinus polyposis, Osteoporosis",
author = "M. Gelardi and F. Barbara and I. Covelli and Damiani, {M. A.} and F. Plantone and A. Notarnicola and B. Moretti and N. Quaranta and G. Ciprandi",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s12070-018-1466-5",
language = "English",
journal = "Indian Journal of Otolaryngology and Head and Neck Surgery",
issn = "2231-3796",
publisher = "Springer India",

}

TY - JOUR

T1 - Long-Term Therapy with Corticosteroids in Nasal Polyposis

T2 - A Bone Metabolism Assessment

AU - Gelardi, M.

AU - Barbara, F.

AU - Covelli, I.

AU - Damiani, M. A.

AU - Plantone, F.

AU - Notarnicola, A.

AU - Moretti, B.

AU - Quaranta, N.

AU - Ciprandi, G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Chronic rhinosinusitis associated with nasal polyposis (RSCwNP) affects 4% of the general population. As chronic condition, it requires chronic pharmacological treatment, whereas the surgical approach becomes necessary in obstructive and/or complicated cases. Intranasal and systemic corticosteroids (CS) represent the “Gold Standard” treatment for RSCwNP. The present study aimed to evaluate the side effects of prednisone in a group of patients with RSCwNP treated with long-term CS. In particular, attention was focused on bone disorders (osteopenia and osteoporosis) and prospective fracture risk increase. Forty patients (26 females, mean age 55.70 ± 14.03 years) affected by RSCwNP have been enrolled. Control group included 40 healthy subjects (17 females, mean age 56.37 ± 13.03 years). Nasal endoscopy, skin prick tests, nasal cytology, and bone densitometry were evaluated in all subjects. The likelihood of impaired bone metabolism (osteopenia or osteoporosis) was superimposable in both groups. Within RSCwNP group, no parameter was statistically significant in predicting a metabolism alteration.

AB - Chronic rhinosinusitis associated with nasal polyposis (RSCwNP) affects 4% of the general population. As chronic condition, it requires chronic pharmacological treatment, whereas the surgical approach becomes necessary in obstructive and/or complicated cases. Intranasal and systemic corticosteroids (CS) represent the “Gold Standard” treatment for RSCwNP. The present study aimed to evaluate the side effects of prednisone in a group of patients with RSCwNP treated with long-term CS. In particular, attention was focused on bone disorders (osteopenia and osteoporosis) and prospective fracture risk increase. Forty patients (26 females, mean age 55.70 ± 14.03 years) affected by RSCwNP have been enrolled. Control group included 40 healthy subjects (17 females, mean age 56.37 ± 13.03 years). Nasal endoscopy, skin prick tests, nasal cytology, and bone densitometry were evaluated in all subjects. The likelihood of impaired bone metabolism (osteopenia or osteoporosis) was superimposable in both groups. Within RSCwNP group, no parameter was statistically significant in predicting a metabolism alteration.

KW - Chronic rhinosinusitis

KW - Corticosteroids

KW - Densitometry

KW - Nose-sinus polyposis

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=85051641712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051641712&partnerID=8YFLogxK

U2 - 10.1007/s12070-018-1466-5

DO - 10.1007/s12070-018-1466-5

M3 - Article

JO - Indian Journal of Otolaryngology and Head and Neck Surgery

JF - Indian Journal of Otolaryngology and Head and Neck Surgery

SN - 2231-3796

ER -